AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Role of AI soars in tackling Covid-19 pandemic
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging from diagnosing risk to doubt-clearing, from delivery of services to drug discovery in tackling the Covid-19 outbreak.
While BlueDoT, a Canadian health monitoring firm that crunches flight data and news reports using AI, is being credited by international reports to be the first to warn its clients of an impending outbreak on December 31, beating countries and international developmental agencies, the Indian tech space too is buzzing with coronavirus cracking activities.
Drugs efficacy and busting fake info
Another start-up, Innoplexus AG, headquartered in Germany but founded by Indians, is claiming that its AI-enabled drug discovery platform is helping to arrive at combinations of existing drugs that may prove more efficacious in treating Covid-19 cases.
Its AI platform, after scanning the ‘entire universe of Covid-related data’ has thrown up results to show that Hydroxycholoroquine or Chroloquine, an anti-malaria drug that is being prescribed as a prophylactic for coronavirus under many protocols works more effectively with some other existing drugs than when it is used alone, the company claims.
“Our analysis shows that Chloroquine works more effectively in combination with Pegasys (a drug used to treat Hepatitis C] or Tocilizumab, (a rheumatoid arthritis drug) or Remdesivir (yet to be approved antiviral drug for Ebola) or Clarithromycin (an antibiotic). We are hoping to work with drug regulators and partners to test these in pre-clinical and clinical trials,” said Gunjan Bhardwaj, CEO, Innoplexus.
To be sure, hundreds of clinical trials are currently under way with several cocktails of medicines for Covid-19 across the world, and some of these drugs were part of trials held in China and Taiwan. The World Health Organization (WHO) itself is monitoring a global mega clinical trial for testing drugs for Covid-19 called ‘solidarity’, which India decided to join on Friday.
Originally published on The Hindu BusinessLine.
Featured News
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience.Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trialsBOSTON and DURHAM, N.C. and ESCHBORN, Germany,…
New app for cancer patients
Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…
Innoplexus wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary…
AI CTP engine estimated failure for Biogen’s aducanumab
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years…
Innoplexus launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be…